Footwear

Shares of apparel retailer Nike (NYSE: NKE) are sitting near their highs for the session, up 10% to $89.73. The company reported much better than expected earnings yesterday after the closing bell and the stock has been accumulated on heavy volume throughout Tuesday's trading session. More than...

Cusick's Corner We have a new XPOUND Design, making the newsletter easier to read both online or on your smart phone. One new design feature allows you to check on the risk/reward ratio of a strategy mentioned in XPOUND by clicking on the "Analyze this Trade" link to help you gain quick access to...

Shares of Nike (NYSE: NKE) are trading higher in today's trading hours following the release of the company's Q4 earnings results yesterday. Currently, shares are higher by 10.06%, at $89.83. NIKE, Inc. reported Q4 EPS of $1.24 on revenues of $5.77 billion; the Street was looking for $1.16 per...

Shares of Nike Inc (NYSE: NKE) gained about 7.2% after the company reported a 14% rise in its fourth-quarter profit. Nike reported its quarterly earnings at $594 million, or $1.24 per share, up from $522 million, or $1.06 per share, in the year-ago quarter. Its revenue surged 14% to $5.77 billion....

NIKE, Inc. (NYSE: NKE) shares are jumping this morning, gaining almost 5% after the company reported better than expected earnings last night after the bell. The Beaverton-based footwear maker reported earnings of $1.24 per share on $5.77 billion in revenues. Wall Street analysts were looking for...

1) Under Armour, Inc. (UA) up on the heels of great Nike, Inc. (NKE) earnings, I'm looking for a trade above $75 on with a hold on a 5 minute basis. Ultimately I'm looking for an ultimate move back to $80. For a day trade can probably see $77-77.50 today. Stops at $74. 2) VirnetX Holding...

Sterne Agee reiterated its Buy rating on Nike (NYSE: NKE). On Monday, Nike ended the day at $81.62. Its shares surged in today's pre-market trading, however, rising 4.63% to $85.40.

Nike (NYSE: NKE) is up nearly 5% in pre-market on higher than expected earnings. The company reported EPS of $1.24 vs. $1.16 estimate and revenues of $5.8B vs. $5.54B estimate. Nike is currently trading at $85.50 in pre-market, which is a gain of 4.75%.

This is your Benzinga news summary and traders' outlook for Tuesday, June 28, 2011, covering headlines from overnight and Tuesday's pre-market session. Today in domestic pre-market trading, U.S. equity futures are trading slightly lower after posting gains yesterday. The U.S. dollar is trading...

US stock futures are slightly lower this morning. Greek Parliament is scheduled to vote Wednesday on the EUR28.4 billion, five-year austerity package. Futures on the Dow Jones Industrial Average dropped 13 points to 11,977.00 and futures on the S&P 500 stock index fell 1.80 points to 1,274.50....

Some of the stocks that may grab investor focus today are: Nike Inc (NYSE: NKE) reported a 14% rise in its fourth-quarter profit. Nike reported its quarterly earnings at $594 million, or $1.24 per share, up from $522 million, or $1.06 per share, in the year-ago quarter. Its revenue surged 14% to $...

The Dow Jones Industrial Index saw a substantial fall on Friday after the European markets were roiled by a sudden and mysterious collapse in several leading Italian banks that trade on the Milan stock exchange. On Monday morning, the news from Europe over their ongoing debt woes was much more...

Nike (NKE), the No. 1 athletic footwear maker, said Q4 EPS rose 17% to $1.24, topping by 8 cents. Sales grew 11% to $5. 8 bil, also beating views. Shares rose 4.5%.

The major indexes scored solid gains Monday, led by the Nasdaq composite's 1.3% advance. But volume decreased across the board from Friday's levels, which were boosted by a rebalancing of the Russell indexes. The lower trade lessened the impact of Monday's move up. The S&P 500 rose 0.9%, while...

Shares of MetLife Inc (NYSE: MET) gained about 0.8% after Franco-Belgian financial services group Dexia SA (OTC: DXBGF) agreed to sell its Turkish life insurance business to MetLife for 162 million euros ($229.3 million). The transaction is likely to close by the end of 2011. MetLife will buy Dexia...